425 related articles for article (PubMed ID: 18537487)
21. Ropinirole treatment for restless legs syndrome.
Chitnis S
Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922
[TBL] [Abstract][Full Text] [Related]
22. Treatment of restless legs syndrome.
Ferini-Strambi L; Manconi M
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S65-70. PubMed ID: 20123560
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
Giorgi L; Ritchie SY; Kirsch JM
Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
[TBL] [Abstract][Full Text] [Related]
24. Restless legs syndrome in the older adult: diagnosis and management.
Milligan SA; Chesson AL
Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
[TBL] [Abstract][Full Text] [Related]
25. Role of dopamine receptor agonists in the treatment of restless legs syndrome.
Happe S; Trenkwalder C
CNS Drugs; 2004; 18(1):27-36. PubMed ID: 14731057
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
Allen RP; Ritchie SY
Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
[TBL] [Abstract][Full Text] [Related]
27. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
[TBL] [Abstract][Full Text] [Related]
28. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of restless legs syndrome in end-stage renal disease patients.
Sahli ZT; Jo J; Mousa SA; Tarazi FI
CNS Spectr; 2017 Feb; 22(1):14-21. PubMed ID: 27702420
[TBL] [Abstract][Full Text] [Related]
31. Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).
Tzonova D; Larrosa O; Calvo E; Granizo JJ; Williams AM; de la Llave Y; García-Borreguero D
Sleep Med; 2012 Feb; 13(2):151-5. PubMed ID: 22281003
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy for restless legs syndrome.
Ferini-Strambi L; Marelli S
Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
[TBL] [Abstract][Full Text] [Related]
33. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
34. [Restless legs syndrome in kidney patients].
Cavallini L; Impedovo A; Abaterusso C; Loschiavo C; Lupo A
G Ital Nefrol; 2010; 27(1):37-46. PubMed ID: 20191459
[TBL] [Abstract][Full Text] [Related]
35. Ropinirole treatment for restless legs syndrome.
Molnar MZ; Fornadi K; Shapiro CM
Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
37. Targeted Pressure on Abductor Hallucis and Flexor Hallucis Brevis Muscles to Manage Moderate to Severe Primary Restless Legs Syndrome.
Kuhn PJ; Olson DJ; Sullivan JP
J Am Osteopath Assoc; 2016 Jul; 116(7):440-50. PubMed ID: 27367949
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
[TBL] [Abstract][Full Text] [Related]
39. Restless legs syndrome: clinical presentation diagnosis and treatment.
Wijemanne S; Jankovic J
Sleep Med; 2015 Jun; 16(6):678-90. PubMed ID: 25979181
[TBL] [Abstract][Full Text] [Related]
40. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
